Web17 dec. 2024 · Presentations Download - 康诺亚生物医药科技成都有限公司. Investor Relations. Presentations Download. Keymed Bio 2024 Interim Results Presentation. 2024-08-30. Keymed Bio 2024 Annual Results Presentation. 2024-03-30. Keymed Bio 2024 Interim Results Presentation. 2024-12-17. http://en.keymedbio.com/uploadfile/2024/0920/20240920044727727.pdf
Contact Information - 康诺亚生物医药科技成都有限公司
[email protected] Beijing. Address Suite 602, Building B, Yonggui Center, No.47 Guangqumen Street, Dongcheng District, Beijing Tel 028-88610620 Email … WebKeyMed Biosciences General Information. Description. Keymed Biosciences Inc is a biotechnology company with multiple clinical-stage assets. The company is focused on the in-house discovery and development of innovative biological therapies that address large underserved medical needs in the autoimmune and oncology therapeutic areas. desvio linea 21 zaragoza
Keymed Biosciences Inc. (2162.HK) - Yahoo Finance
Web12 apr. 2024 · Keymed Biosciences Inc., a biotechnology company, engages in the research and development of biological therapies for the treatment of autoimmunity and oncology diseases. About the company Rewards Trading at 70.8% below our estimate of its fair value Revenue is forecast to grow 43.53% per year Risk Analysis Web18 jan. 2024 · Keymed Biosciences is a biotechnology company focused on the in-house discovery and development of innovative biological therapies in the autoimmune and oncology therapeutic areas. Web1 抗体偶联药物 科学技术平台 满足NMPA、FDA、EMA的GMP标准 高效集成的自主研发生产,综合性一体化生物医药技术平台,创新能力贯穿研发、生产及未来商业运营全产业链 … 关于康诺亚 - 康诺亚生物 - Keymed Biosciences 首页 多 关于康诺亚 0 21年 … detailing oprema promo kod